Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 4/1998

01-03-1998 | Original Articles

Correlates and prevalence of benzodiazepine use in community-dwelling elderly

Authors: Dr. Patrick P. Gleason, PharmD, Richard Schulz, PhD, Nicholas L. Smith, MPH, Jason T. Newsom, PhD, Patricia D. Kroboth, PhD, Frank J. Kroboth, MD, Bruce M. Psaty, MD, PhD

Published in: Journal of General Internal Medicine | Issue 4/1998

Login to get access
Metadata
Title
Correlates and prevalence of benzodiazepine use in community-dwelling elderly
Authors
Dr. Patrick P. Gleason, PharmD
Richard Schulz, PhD
Nicholas L. Smith, MPH
Jason T. Newsom, PhD
Patricia D. Kroboth, PhD
Frank J. Kroboth, MD
Bruce M. Psaty, MD, PhD
Publication date
01-03-1998
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 4/1998
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1046/j.1525-1497.1998.00074.x

Other articles of this Issue 4/1998

Journal of General Internal Medicine 4/1998 Go to the issue

Letters To The Editor

Disclosing medical mistakes

Original Articles

Does delirium contribute to poor hospital outcomes?

Original Articles

The relation between health status changes and patient satisfaction in older hospitalized medical patients

BookReview

Book review

Original Articles

Screening for problem drinking

Brief Reports

Patients’ desires and expectations for medical care in primary care clinics
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits